Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.


In response to stress, the heart undergoes extensive cardiac remodeling that results in cardiac fibrosis and pathological growth of cardiomyocytes (hypertrophy), which contribute to heart failure. Alterations in microRNA (miRNA) levels are associated with dysfunctional gene expression profiles associated with many cardiovascular disease conditions; however, miRNAs have emerged recently as paracrine signaling mediators. Thus, we investigated a potential paracrine miRNA crosstalk between cardiac fibroblasts and cardiomyocytes and found that cardiac fibroblasts secrete miRNA-enriched exosomes. Surprisingly, evaluation of the miRNA content of cardiac fibroblast-derived exosomes revealed a relatively high abundance of many miRNA passenger strands ("star" miRNAs), which normally undergo intracellular degradation. Using confocal imaging and coculture assays, we identified fibroblast exosomal-derived miR-21_3p (miR-21*) as a potent paracrine-acting RNA molecule that induces cardiomyocyte hypertrophy. Proteome profiling identified sorbin and SH3 domain-containing protein 2 (SORBS2) and PDZ and LIM domain 5 (PDLIM5) as miR-21* targets, and silencing SORBS2 or PDLIM5 in cardiomyocytes induced hypertrophy. Pharmacological inhibition of miR-21* in a mouse model of Ang II-induced cardiac hypertrophy attenuated pathology. These findings demonstrate that cardiac fibroblasts secrete star miRNA-enriched exosomes and identify fibroblast-derived miR-21* as a paracrine signaling mediator of cardiomyocyte hypertrophy that has potential as a therapeutic target.

DOI: 10.1172/JCI70577

7 Figures and Tables

Citations per Year

1,021 Citations

Semantic Scholar estimates that this publication has 1,021 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Bang2014CardiacFM, title={Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.}, author={Claudia Bang and S{\'a}ndor B{\'a}tkai and Seema Dangwal and Shashi Kumar Gupta and Ariana Foinquinos and Angelika Holzmann and Annette Just and Janet Remke and Karina Zimmer and Andre Zeug and Evgeni G. Ponimaskin and Andreas Schmiedl and Xiaoke Yin and Manuel Mayr and Rashi Halder and Andr{\'e} Fischer and Stefan Engelhardt and Yuanyuan Wei and Andreas Schober and Jan Fiedler and Thomas Thum}, journal={The Journal of clinical investigation}, year={2014}, volume={124 5}, pages={2136-46} }